The Clayton Foundation for Research and its supporting entities currently conduct and fund medical research programs that apply to various indications, including:
Cancer
CNS
Ophthalmology
Metabolic diseases
Infectious diseases
Autoimmune and inflammation
Women's health
Cardiology
…and to different modalities:
Cell and gene therapeutics
Antibodies and biologics
Small molecules
Diagnostics
Probiotics
Medical devices
Current research include:
Tumor targeting toxins
Monoclonal antibody delivery systems
Development of Novel Therapeutic Strategies for Hepatocellular Carcinoma
Drug Delivery systems for treating solid tumors
Engineered proteases and next generation protein therapeutics
Fc engineered aglycosylated antibodies
Bifunctional molecules for rapid protein clearance from blood
Stem cell therapy for Parkinson's Disease
New mechanisms and therapeutics for brain injury
Gene and protein therapies for ocular diseases
Early detection and treatment of glaucoma
Optimization and Characterization of AAV for Gene Therapy
Microbiome and treatment of metabolic diseases such as obesity
Vaccines and diagnostics for Ehrlichioses
Drug discovery program to host-based antiviral targets
The Use of Light for Cardiological, Surgical and Related Purposes
Electroceutical therapies for safe and targeted therapies
Development of Artificial Neurotransmitter Systems
Novel Biologically Active Peptides and Small Proteins (microproteins)
The Morf Veuss Discovery, Screening, and Therapeutics Platform
Identification of Functional Markers for Developing Side Effect-free Non-opioid Analgesics
